586-62-9

Applied Filters:

Keyword:'586-62-9'

Showing 1-1 of 1 result for "586-62-9" within Papers

Plasma heparanase as a significant marker of treatment response in children with Hodgkin lymphoma: pilot study.

Myriam Weyl Ben Arush et al.

Pediatric hematology and oncology, 26(4), 157-164 (2009-05-14)

The aim of this pilot study was to determine heparanase plasma levels (HP) at diagnosis and at restaging in children diagnosed with Hodgkin lymphoma and to investigate whether this parameter provides prognostic information for response to treatment after induction therapy.

Page 1 of 1